Technavio analyzes that the Bioprocess Bags Market is expected to grow at a CAGR of 17.33% during 2023 and 2028. During this period, the market is also expected to show a growth of USD 4173.2 million.There are various factors that contribute to the growth of the market. The bioprocessing industry is witnessing a significant trend towards the adoption of single-use technologies. This shift is driven by several factors, including cost savings, improved productivity, and increased flexibility. Single-use bioprocess bags offer numerous advantages, such as eliminating the need for cleaning and sterilization between batches, reducing downtime, and ensuring consistent process performance. As a result, the market for bioprocess bags is expected to grow at a robust rate in the coming years.
In the upstream processing phase of bioprocessing, single-use technologies have emerged as a game-changer. Traditional stainless-steel systems for cell cultivation and preparation are being replaced with single-use bioreactors, bags, and containers. This shift offers significant advantages, including increased flexibility, cost efficiency, and seamless scale-up for large-production batches. Single-use bioreactors eliminate the need for extensive cleaning and sterilization, thereby reducing the risk of cross-contamination. Moreover, fed-batch processes, prevalent in upstream processing, benefit from the integration of single-use technologies and consumables, enabling precise control over nutrient addition.
Know which region is leading the market growth by requesting a sample report
Bioprocess Bags Market Segmentation
As per our research findings, here are some of the key competitors that are leading the industry
Find out what is trending in the market by accessing the free PDF report
The Bioprocess Bags market encompasses a range of flexible plastic containers designed for various applications in biopharmaceutical manufacturing. These bags are essential for cell culture, media preparation and storage, cell harvesting, and bulk API transport in the production of monoclonal antibodies, biopharmaceuticals, cell therapy products, blood products, vaccines, and other biopharmaceutical products. Bioprocess bags come in various forms, including 2D bioprocess bags and sterile bioreactor bags. They are made of multi-layered films with mechanical properties suitable for cold storage applications and a wide temperature range. Sampling from these bags is facilitated through specialized systems to maintain sterility and product integrity. Disposable bioprocess bags and single use systems are increasingly popular due to their ease of use, cost-effectiveness, and reduced contamination risk. The market for bioprocess bags is driven by the growing demand for personalized medicine and the increasing adoption of single use technologies in biopharmaceutical manufacturing. Temperature-controlled cold storage applications are a significant market for bioprocess bags, as they are used to store sensitive biopharmaceutical products during various stages of production.
According to Technavio, the global Bioprocess Bags Market is a segment of the expansive Global Healthcare Equipment Market. This market encompasses businesses and research institutions involved in the development of various product categories, including capital equipment, instruments, implants, accessories, and consumables. The Global Healthcare Equipment Market, a constituent of the broader Global Healthcare Market, reported a valuation of USDx billion in 2023. Technavio determines the market size by aggregating the revenues of manufacturers producing diagnostic equipment and devices employed across diverse therapy areas.. Industries are leveraging the products belonging to the market for customer engagement, transactional notifications, and promotional offers.
Technavio Research
Jesse Maida
Media & Marketing Executive
US: +1 844 364 1100
UK: +44 203 893 3200
Email: media@technavio.com
Website: www.technavio.com/
Safe and Secure SSL Encrypted